Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2005

View Archived Issues

Small Bone Innovations launches thumb arthritis implant from Artimplant

Allograft bone plus rhBMP-2 shows promise in diaphyseal tibial fractures

rhBMP-2 formulation enhances lumbar spine fusion

Sustained-release epidural morphine effective in reducing knee surgery pain

Retaane safe in patients with macular degeneration

Acyline induces long-term gonadotropin, testosterone suppression

Multiple aviscumine doses evaluated in phase I trial in advanced cancer patients

Aldose reductase inhibitors recommended for diabetic neuropathy

Avian flu clinical trials to begin next month for Alferon N

Clinical studies evaluate the PK profile of febuxostat

BAY-43-9006 under phase II clinical evaluation for AIPC

Testosterone suppression reported with abiraterone acetate in prostate cancer patients

CC-4047 found to decrease PSA levels in patients with HRPC

Avastin shows promise for wet AMD

Complete and partial responses in phase I/II study of MDX-010 for metastatic melanoma

Seroquel findings reported at AAGP meeting

Enrollment completed in pivotal study of five-day Factive for CAP

Johnson & Johnson to acquire TransForm Pharmaceuticals

Ceplene designated orphan drug in Europe for AML

Enrollment completed in three-year Enteryx procedure trial

DNA testing may improve safety of Strattera

Pharming expands hereditary angioedema trials of rhC1INH to Canada

sanofi pasteur launches preservative-free formulation of pediatric flu vaccine

Zila's OraTest clinical program amendments draw preliminary FDA comments

Age and gender do not affect pharmacokinetics of solifenacin

Clinical candidate for depression, anxiety and ADHD presented at the ACS meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...